[–]ABcann_AMA[S] 5 points 5 days ago
Everyone is striving for similar things in this sector. Great product, high margins, low costs of goods, the best product and reputations. It's the same across the board. Our areas we like to focus on are very well known;
Standardized product that the patients can rely on, with very little variance every time they buy it. That's number one. As this will always set you apart with a specific patient population and also be readily accepted in the medical community as well as recreational. So that's the consumer level.
Our yield is obviously important also.
In a year, we want to see ABcann having the doors opened on Kimmet, Van Luven at capacity, hopefully working very closely with SYqe, and have at least two major international opportunities that are in the pipeline into full development or a major part of our revenue stream.
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM